Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Detke, Michael
66  Ergebnisse:
Personensuche X
?
1

Phase 2 Study Design and New Data from the Phase 1 SAD/MAD ..:

Detke, Michael ; Sabbagh, Marwan ; Holsinger, Leslie J...
Alzheimer's & Dementia.  19 (2023)  S24 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
2

COR388 for the Treatment of Alzheimer's Disease (4098):

Detke, Michael ; Lynch, Casey ; Holsinger, Leslie...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
3

Measures of outcome for stimulant trials: ACTTION recommend..:

Kiluk, Brian D. ; Carroll, Kathleen M. ; Duhig, Amy...
Drug and Alcohol Dependence.  158 (2016)  - p. 1-7 , 2016
Link: https://doi.org/10.1016/..
 
?
4

APN1125: A clinical stage α7 nicotinic acetylcholine recept..:

Koelsch, Gerald ; Detke, Michael J. ; Stevens, Karen E....
Biochemical Pharmacology.  97 (2015)  4 - p. 636 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Controlling Placebo Response in Drug Development: Lessons L..:

Potter, William Z. ; Mallinckrodt, Craig H. ; Detke, Michael J.
Pharmaceutical Medicine.  28 (2014)  2 - p. 53-65 , 2014
Link: https://doi.org/10.1007/..
 
?
6

A 6-week randomized, double-blind, placebo-controlled, comp..:

Shen, Joan H.Q. ; Zhao, Yonggang ; Rosenzweig-Lipson, Sharon...
Journal of Psychiatric Research.  53 (2014)  - p. 14-22 , 2014
Link: https://doi.org/10.1016/..
 
?
7

P2‐304: Guidelines for reporting clinical trial methodology..:

Popp, Danielle ; Williams, Janet B.W. ; Sorantin, Peter.
Alzheimer's & Dementia.  8 (2012)  4S_Part_10 - p. , 2012
Link: https://doi.org/10.1016/..
 
?
8

P3‐382: The role of expectation bias in neurocognitive clin..:

Popp, Danielle ; Williams, Janet ; Kobak, Kenneth..
Alzheimer's & Dementia.  8 (2012)  4S_Part_16 - p. , 2012
Link: https://doi.org/10.1016/..
 
?
9

Sexual Function During Long-Term Duloxetine Treatment in Pa..:

Montejo, Angel-Luis ; Perahia, David G.S. ; Spann, Melissa E....
The Journal of Sexual Medicine.  8 (2011)  3 - p. 773-782 , 2011
Link: https://doi.org/10.1111/..
 
?
10

Considerations for Using Positive Controls in Phase 2 Clini..:

Mallinckrodt, Craig H. ; Detke, Michael J. ; Prucka, William R...
Drug Information Journal.  44 (2010)  4 - p. 431-441 , 2010
Link: https://doi.org/10.1177/..
 
?
11

IMPROVING SIGNAL DETECTION IN SCHIZOPHRENIA CLINICAL TRIALS:

Detke, Michael
Schizophrenia Research.  117 (2010)  2-3 - p. 138 , 2010
Link: https://doi.org/10.1016/..
 
?
12

Design Archetypes for Phase 2 Clinical Trials in Central Ne..:

Mallinckrodt, Craig H. ; Detke, Michael J. ; Prucka, William R...
Drug Information Journal.  44 (2010)  4 - p. 421-430 , 2010
Link: https://doi.org/10.1177/..
 
?
13

THE CHALLENGE OF PATIENT ASCERTAINMENT IN CLINICAL TRIALS –..:

Detke, Michael ; Williams, Janet ; Kobath, Kenneth...
Schizophrenia Research.  117 (2010)  2-3 - p. 406 , 2010
Link: https://doi.org/10.1016/..
 
?
14

Considerations for Comparing a Test Drug with Standard of C..:

Mallinckrodt, Craig H. ; Detke, Michael J. ; Prucka, William R...
Drug Information Journal.  44 (2010)  4 - p. 443-452 , 2010
Link: https://doi.org/10.1177/..
 
?
15

Long-Term Safety, Tolerability, and Efficacy of Duloxetine ..:

Mease, Philip J. ; Russell, I. Jon ; Kajdasz, Daniel K....
Seminars in Arthritis and Rheumatism.  39 (2010)  6 - p. 454-464 , 2010
Link: https://doi.org/10.1016/..
 
1-15